Virtual Medicinal Product (VMP)
-
Azelastine 140micrograms/dose nasal spray
Name Details
Current Name
Azelastine 140micrograms/dose nasal spray
|
Start Date
25-02-2010
|
End Date
|
Previous Name
Azelastine 140micrograms/actuation nasal spray
|
Start Date
07-01-2003
|
End Date
24-02-2010
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- actuation
- Unit Dose UOM
- actuation
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Nasal
- Form
- Spray
- Ontology Form/Route
- solutionspray.nasal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
R01AC03
BNF |
Current BNF
12020100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
12020100
|
Start Date
17-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42185111000001104 |
25-08-2023 |
|
331057004 |
07-01-2003 |
24-08-2023 |
VMP Ingredients
Name
Azelastine hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
140
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Azelastine
-
VMP
(Current) Azelastine 140micrograms/dose nasal ...
Virtual Medicinal Product Pack (VMPP) Information